Intravenous infusion of mesenchymal stem cells is associated with improved myocardial function during endotoxemia

Shock

Volumn 36, Issue 3, 2011, Pages 235-241

  Weil, Brent R ^a   Herrmann, Jeremy L ^a   Abarbanell, Aaron M ^a   Manukyan, Mariuxi C ^a   Poynter, Jeffrey A ^a   Meldrum, Daniel R ^a,b,c  

^a Department of Surgery ^*  (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INDIANA UNIVERSITY HEALTH   (United States)

Author keywords

echocardiography; immunomodulation; inflammation; myocardial dysfunction; progenitor cells; Sepsis; tumor necrosis factor

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENDOTOXEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE; HUMAN; HUMAN CELL; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MESENCHYMAL STEM CELL; NONHUMAN; RAT; SERUM;

ANIMALS; CELLS, CULTURED; ECHOCARDIOGRAPHY; ENDOTOXEMIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; INFUSIONS, INTRAVENOUS; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80052032207     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e318225f6ae     Document Type: Article

References (32)

1. Fernandes CJ Jr, Akamine N, Knobel E: Myocardial depression in sepsis. Shock 30(Suppl 1):14-17, 2008.
2. Zanotti-Cavazzoni SL, Hollenberg SM: Cardiac dysfunction in severe sepsis and septic shock. Curr Opin Crit Care 15:392-397, 2009.
3. Levy RJ: Mitochondrial dysfunction, bioenergetic impairment, and metabolic down-regulation in sepsis. Shock 28:24-28, 2007. (Pubitemid 46956458)
4. Parrillo JE, Burch C, Shelhamer JH, Parker MM, Natanson C, Schuette W: A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest 76: 1539-1553, 1985. (Pubitemid 16193573)
5. Meldrum DR: Tumor necrosis factor in the heart. Am J Physiol 274:R577-R595, 1998.
6. Meng X, Ao L, Meldrum DR, Cain BS, Shames BD, Selzman CH, Banerjee A, Harken AH: TNF-alpha and myocardial depression in endotoxemic rats: temporal discordance of an obligatory relationship. Am J Physiol 275:R502-R508, 1998.
7. Nauta AJ, Fibbe WE: Immunomodulatory properties of mesenchymal stromal cells. Blood 110:3499-3506, 2007. (Pubitemid 350159613)
8. Nemeth K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, Robey PG, Leelahavanichkul K, Koller BH, Brown JM, et al.: Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15:42-49, 2009.
9. Weil BR, Herrmann JL, Abarbanell AM, Manukyan MC, Poynter JA, Meldrum DR: Mesenchymal stem cells attenuate myocardial functional depression and reduce systemic and myocardial inflammation during endotoxemia. Surgery 148:444-452, 2010.
10. Xu J, Woods CR, Mora AL, Joodi R, Brigham KL, Iyer S, Rojas M: Prevention of endotoxin-induced systemic response by bone marrowYderived mesenchymal stem cells in mice. Am J Physiol Lung Cell Mol Physiol 293:L131-L141, 2007. (Pubitemid 47080721)
11. Gupta N, Su X, Popov B, Lee JW, Serikov V, Matthay MA: Intrapulmonary delivery of bone marrowYderived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 179:1855-1863, 2007.
12. Gonzalez-Rey E, Anderson P, Gonzalez MA, Rico L, Buscher D, Delgado M: Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut 58:929-939, 2009.
13. Lee JW, Fang X, Gupta N, Serikov V, Matthay MA: Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxinYinduced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci USA 106: 16357-16362, 2009.
14. Weil BR, Markel TA, Herrmann JL, Abarbanell AM, Kelly ML, Meldrum DR: Stem cells in sepsis. Ann Surg 250:19-27, 2009.
15. Sun S, Guo Z, Xiao X, Liu B, Liu X, Tang PH, Mao N: Isolation of mouse marrow mesenchymal progenitors by a novel and reliable method. Stem Cells 21:527-535, 2003. (Pubitemid 37444109)
16. Abarbanell AM, Wang Y, Herrmann JL, Weil BR, Poynter JA, Manukyan MC, Meldrum DR: Toll-like receptor 2 mediates mesenchymal stem cellYassociated myocardial recovery and VEGF production following acute ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 298:H1529-H1536, 2010.
17. Reim D, Westenfelder K, Kaiser-Moore S, Schlautkotter S, Holzmann B, Weighardt H: Role of T cells for cytokine production and outcome in a model of acute septic peritonitis. Shock 31:245-250, 2009.
18. Spaggiari GM, Abdelrazik H, Becchetti F, Moretta L: MSCs inhibit monocytederived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood 113:6576-6583, 2009.
19. Kim J, Hematti P: Mesenchymal stem cellYeducated macrophages: a novel type of alternatively activated macrophages. Exp Hematol 37:1445-1453, 2009.
20. Maass DL, White J, Horton JW: IL-1beta and IL-6 act synergistically with TNFalpha to alter cardiac contractile function after burn trauma. Shock 18:360-366, 2002.
21. Sharma AC: Sepsis-induced myocardial dysfunction. Shock 28:265-269, 2007. (Pubitemid 47282016)
22. Rossi MA, Celes MR, Prado CM, Saggioro FP: Myocardial structural changes in long-term human severe sepsis/septic shock may be responsible for cardiac dysfunction. Shock 27:10-18, 2007. (Pubitemid 44968004)
23. Crisostomo PR, Wang M, Markel TA, Lahm T, Abarbanell AM, Herrmann JL, Meldrum DR: Stem cell mechanisms and paracrine effects: potential in cardiac surgery. Shock 28:375-383, 2007. (Pubitemid 47415247)
24. Chamberlain G, Fox J, Ashton B, Middleton J: Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25:2739-2749, 2007. (Pubitemid 350127858)
25. Crisostomo PR, Wang Y, Markel TA, Wang M, Lahm T, Meldrum DR: Human mesenchymal stem cells stimulated by TNF-{alpha}, LPS, or hypoxia produce growth factors by an NF{kappa}B-but not JNK-dependent mechanism. Am J Physiol Cell Physiol 294:C675-C682, 2008. (Pubitemid 351468685)
26. Wang M, Crisostomo PR, Herring C, Meldrum KK, Meldrum DR: Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism. Am J Physiol Regul Integr Comp Physiol 291:R880-R884, 2006. (Pubitemid 44498426)
27. Rasmusson I: Immune modulation by mesenchymal stem cells. Exp Cell Res 312:2169-2179, 2006. (Pubitemid 43928946)
28. Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, Gerdoni E, Giunti D, Ceravolo A, Cazzanti F, Frassoni F, et al.: Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106:1755-1761, 2005. (Pubitemid 41208591)
29. Aggarwal S, Pittenger MF: Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815-1822, 2005. (Pubitemid 40223708)
30. Unsinger J, Kazama H, McDonough JS, Griffith TS, Hotchkiss RS, Ferguson TA: Sepsis-induced apoptosis leads to active suppression of delayed-type hypersensitivity by CD8+ regulatory T cells through a TRAIL-dependent mechanism. J Immunol 184:6766-6772, 2010.
31. Brahmamdam P, Watanabe E, Unsinger J, Chang KC, Schierding W, Hoekzema AS, Zhou TT, McDonough JS, Holemon H, Heidel JD, et al.: Targeted delivery of siRNA to cell death proteins in sepsis. Shock 32:131-139, 2009.
32. Hubbard WJ, Choudhry M, Schwacha MG, Kerby JD, Rue LW 3rd, Bland KI, Chaudry IH: Cecal ligation and puncture. Shock 24(Suppl 1):52-57, 2005.